Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motohiro Nonaka

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
BMC Cancer|January 15, 2021
Tumor vasculature-targeted <sup>10</sup>B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapyTohru Yoneyama, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, et al.
Journal of Biochemistry|February 2, 2026
Urinary excretion of nonsulfated HNK-1 glycans is associated with renal dysfunctionHajime Okayama, Nanako Iikura, Daisuke Takakura, et al.
BMC Cancer|January 30, 2021
Correction to: Tumor vasculature-targeted 10B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapyTohru Yoneyama, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, et al.
The Journal of Biological Chemistry|June 24, 2015
A Cytotoxic Antibody Recognizing Lacto-N-fucopentaose I (LNFP I) on Human Induced Pluripotent Stem (hiPS) CellsShogo Matsumoto, Hiromi Nakao, Keiko Kawabe, et al.
The FEBS Journal|April 25, 2026
Neudesin modulates IGF1 and insulin signaling pathways by regulating the surface expression of IGF1R through a conserved WPE motifYoshiaki Nakayama, Motohiro Nonaka, Yuki Masuda, et al.
Glycobiology|November 17, 2012
A novel antibody for human induced pluripotent stem cells and embryonic stem cells recognizes a type of keratan sulfate lacking oversulfated structuresKeiko Kawabe, Daiki Tateyama, Hidenao Toyoda, et al.
Plos One|January 6, 2021
Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptidesMotohiro Nonaka, Hideaki Mabashi-Asazuma, Donald L Jarvis, et al.
The Journal of Biological Chemistry|April 23, 2014
Carbohydrate sequence of the prostate cancer-associated antigen F77 assigned by a mucin O-glycome designer arrayChao Gao, Yan Liu, Hongtao Zhang, et al.
British Journal of Cancer|September 14, 2020
Overcoming the blood-brain barrier by Annexin A1-binding peptide to target brain tumoursMotohiro Nonaka, Misa Suzuki-Anekoji, Jun Nakayama, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
BMC Cancer|January 15, 2021
Tumor vasculature-targeted <sup>10</sup>B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapyTohru Yoneyama, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, et al.
Journal of Biochemistry|February 2, 2026
Urinary excretion of nonsulfated HNK-1 glycans is associated with renal dysfunctionHajime Okayama, Nanako Iikura, Daisuke Takakura, et al.
BMC Cancer|January 30, 2021
Correction to: Tumor vasculature-targeted 10B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapyTohru Yoneyama, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, et al.
The Journal of Biological Chemistry|June 24, 2015
A Cytotoxic Antibody Recognizing Lacto-N-fucopentaose I (LNFP I) on Human Induced Pluripotent Stem (hiPS) CellsShogo Matsumoto, Hiromi Nakao, Keiko Kawabe, et al.
The FEBS Journal|April 25, 2026
Neudesin modulates IGF1 and insulin signaling pathways by regulating the surface expression of IGF1R through a conserved WPE motifYoshiaki Nakayama, Motohiro Nonaka, Yuki Masuda, et al.
Glycobiology|November 17, 2012
A novel antibody for human induced pluripotent stem cells and embryonic stem cells recognizes a type of keratan sulfate lacking oversulfated structuresKeiko Kawabe, Daiki Tateyama, Hidenao Toyoda, et al.
Plos One|January 6, 2021
Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptidesMotohiro Nonaka, Hideaki Mabashi-Asazuma, Donald L Jarvis, et al.
The Journal of Biological Chemistry|April 23, 2014
Carbohydrate sequence of the prostate cancer-associated antigen F77 assigned by a mucin O-glycome designer arrayChao Gao, Yan Liu, Hongtao Zhang, et al.
British Journal of Cancer|September 14, 2020
Overcoming the blood-brain barrier by Annexin A1-binding peptide to target brain tumoursMotohiro Nonaka, Misa Suzuki-Anekoji, Jun Nakayama, et al.
Pageof 4